STOCK TITAN

Alvotech (NASDAQ: ALVO) reports major share buys by associated entities

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Alvotech reported share purchases in the company by entities closely associated with its leadership. On January 6, 2026, it announced that Alvogen Lux Holdings S.a. r.l., a person closely associated with senior management and board members, acquired 7,007,321 Alvotech shares on December 17, 2025 at SEK 44.06 per share. The company also announced that ATP Holdings ehf. acquired 4,812,257 Alvotech shares on December 17, 2025 at SEK 44.06 per share and a further 2,110,640 shares on December 19, 2025 at the same price. These transactions were notified to the Luxembourg financial regulator using HOS-2 forms, which are furnished as exhibits to this report.

Positive

  • None.

Negative

  • None.
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2026

Commission File Number: 001-41421

Alvotech
(Translation of registrant's name into English)

9, Rue de Bitbourg,
L-1273 Luxembourg,
Grand Duchy of Luxembourg

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

 

 

 

 

Incorporation by Reference

This Report on Form 6-K (this “Report”) of Alvotech (the “Company”) excluding Exhibit 99.1, 99.2 and 99.3 attached hereto, shall be deemed to be incorporated by reference into the Company’s registration statements on Forms F-3 (File Nos. 333-266136, 333-273262, 333-275111 and 333-281684), the Company’s registration statement on Form F-3ASR (File No. 333-289006), and the Company’s registration statement on Form S-8 (File No. 333-266881) and to be a part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibit 99.1, 99.2 and 99.3 to this Report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Company Announcements

On January 6, 2026, the Company announced that according to a form filed with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, Alvogen Lux Holdings S.a. r.l. had reported the acquisition of 7,007,321 shares in Alvotech at a price of SEK 44.06 per share. The date of the transaction was December 17, 2025. A copy of the form is furnished herewith as Exhibit 99.1.

On January 6, 2026, the Company also announced that according to a form filed with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, ATP Holdings ehf. had reported the acquisition of 4,812,257 shares in Alvotech on December 17, 2025, at SEK 44.06 per share and 2,110,640 shares in Alvotech on December 19, 2025, at SEK 44.06 per share. Copies of these forms are furnished herewith as Exhibit 99.2 and Exhibit 99.3.

 

 

 

EXHIBIT INDEX

 

Exhibit Number Description
   
99.1 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (HOS-2 form)
99.2 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (HOS-2 form)
99.3 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (HOS-2 form)

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Alvotech    
  (Registrant)
   
  
Date: January 7, 2026     /s/ Tanya Zharov    
  Tanya Zharov
  General Counsel
  

Exhibit 99.1

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (HOS-2 form)

 

Filing reference  
Submitted at  

 

1.    Details of the person discharging managerial responsibilities/person closely associated

 

Name1 Alvogen Lux Holdings Sarl

 

2.Reason for the notification

 

Position/status2 Person closely associated with (i) Robert Wessman, CEO and Chairman of the Board of Directors; (ii) Tomas Ekman, Board Member; and (iii) Arni Hardarson, Board Member
Initial notification/Amendment3 Initial notification

 

3.   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Name4 Alvotech
LEI5 222100DCZBOWV5DZ8372

 

4.   Details of the transaction(s): section to be repeated for 1 each type of instrument; 2 each type of transaction; 3 each date; and 4 each place where transactions have been conducted:

 

Description of the financial instrument, type of instrument6 Shares
Identification code7 LU2458332611
Nature of the transaction8 Acquisition
Price(s) and volume(s)9 Price(s) Volume(s)
44.06 SEK 7,007,321 (units)

Aggregated information

Aggregated volume10

Price11

 

7,007,321

(units) 44.06 SEK

Date of the transaction12 2025-12-17
Place of transaction13

- XOFF 

 

 

 

Notes

1 For natural persons: the first name and the last name(s). For legal persons: full name including legal form as provided for in the register where it is incorporated, if applicable.

2 For persons discharging managerial responsibilities: the position occupied within the issuer, emission allowances market participant/auction platform/auctioneer/auction monitor should be indicated, e.g. CEO, CFO. For persons closely accociated:

An indication that the notification concerns a person closely associated with a person discharging managerial responsibilities;
Name and position of the relevant person discharging managerial responsibilities.

3 Indication that this is an initial notification or an amendment to prior notifications. In case of amendment, explain the error that this notification is amending.

4 Full name of the entity.

5 Legal Entity Identifier code in accordance with ISO 17442 LEI code.

6 Indication as to the nature of the instrument:

A share, a debt instrument, a derivative or a financial instrument linked to a share or a debt instrument;
An emission allowance, an auction product based on an emission allowance or a derivative relating to an emission allowance.

7 Instrument identification code as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

8 Description of the transaction type using, where applicable, the type of transaction identified in Article 10 of the Commission Delegated Regulation (EU) 2016/522 adopted under Article 19(14) of Regulation (EU) No 596/2014 or a specific example set out in Article 19(7) of Regulation (EU) No 596/2014. Pursuant to Article 19(6)(e) of Regulation (EU) No 596/2014, it shall be indicated whether the transaction is linked to the exercise of a share option programme.

9 Where more than one transaction of the same nature (purchases, sales, lendings, borrows, ...) on the same financial instrument or emission allowance are executed on the same day and on the same place of transaction, prices and volumes of these transactions shall be reported in this field, in a two columns form as presented above, inserting as many lines as needed. Using the data standards for price and quantity, including where applicable the price currency and the quantity currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

10 The volumes of multiple transactions are aggregated when these transactions:

Relate to the same financial instrument or emission allowance;
Are of the same nature;
Are executed on the same day;
And are executed on the same place of transaction.

Using the data standard for quantity, including where applicable the quantity currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

11 Price information:

In case of a single transaction, the price of the single transaction;
In case the volumes of multiple transactions are aggregated: the weighted average price of the aggregated transactions.

Using the data standard for price, including where applicable the price currency, as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014.

12 Date of the particular day of execution of the notified transaction. Using the ISO 8601 date format: YYYY-MM-DD; UTC time.

13 Name and code to identify the MiFID trading venue, the systematic internaliser or the organised trading platform outside of the Union where the transaction was executed as defined under Commission Delegated Regulation supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the reporting of transactions to competent authorities adopted under Article 26 of Regulation (EU) No 600/2014, or if the transaction was not executed on any of the above mentioned venues, please mention "outside a trading venue".

 

 

FAQ

What did Alvotech (ALVO) disclose in this Form 6-K?

Alvotech disclosed that entities closely associated with its management and board reported large acquisitions of Alvotech shares in December 2025, as notified to the Luxembourg financial regulator and furnished as HOS-2 forms.

How many Alvotech shares did Alvogen Lux Holdings S.a. r.l. acquire?

Alvogen Lux Holdings S.a. r.l. reported acquiring 7,007,321 Alvotech shares on December 17, 2025 at a price of SEK 44.06 per share, according to the notification included in the Form 6-K.

What share purchases by ATP Holdings ehf. were reported for Alvotech (ALVO)?

ATP Holdings ehf. reported acquiring 4,812,257 Alvotech shares on December 17, 2025 at SEK 44.06 per share and an additional 2,110,640 shares on December 19, 2025 at the same price.

Are these Alvotech share transactions by insiders or related parties?

The transactions were reported on forms for persons discharging managerial responsibilities and persons closely associated with them. Alvogen Lux Holdings S.a. r.l. is described as closely associated with the CEO and board members, and ATP Holdings ehf. is also identified as a closely associated person.

At what price were the reported Alvotech (ALVO) shares acquired?

All of the reported transactions by Alvogen Lux Holdings S.a. r.l. and ATP Holdings ehf. were executed at a price of SEK 44.06 per Alvotech share, according to the disclosures.

Are the exhibits in this Alvotech Form 6-K considered filed or furnished?

The company states that Exhibits 99.1, 99.2 and 99.3 are being furnished and are not deemed “filed” for purposes of Section 18 of the Exchange Act, nor incorporated by reference into Securities Act or Exchange Act filings.

Is this Alvotech Form 6-K incorporated into other SEC registration statements?

The Form 6-K, excluding Exhibits 99.1, 99.2 and 99.3, is incorporated by reference into Alvotech’s Form F-3 and Form S-8 registration statements listed in the document.

Alvotech

NASDAQ:ALVO

ALVO Rankings

ALVO Latest News

ALVO Latest SEC Filings

ALVO Stock Data

1.54B
117.87M
61.79%
6.49%
0.47%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg City